HR6259-119

In Committee

No Fentanyl on Social Media Act

119th Congress Introduced Nov 21, 2025

Summary

What This Bill Does

The No Fentanyl on Social Media Act requires the Federal Trade Commission, in coordination with HHS through the FDA Commissioner and the Drug Enforcement Administration, to submit and publish within one year a report on minors’ ability to access fentanyl, pressed pills, fentanyl analogues, and fentanyl-related substances through social media platforms. The report must cover prevalence, health and physical-safety risks to minors, how sellers use platforms to market and transact fentanyl, how platform design features affect access, platform practices and their effectiveness, measures by law enforcement and the medical community, and recommendations for Congress. The FTC must consult parents, social media platforms, law enforcement, medical professionals, and other experts, and may redact information about seller methods or countermeasures if the Attorney General agrees disclosure could compromise law-enforcement tactics.

Who Benefits and How

Minors and parents benefit from a Federal study focused on how fentanyl sellers reach young users through social media and what Congress can do about it. Congress benefits from recommendations, platform-practice analysis, and information about law-enforcement and medical responses. Law enforcement and medical professionals gain a formal consultation channel.

Who Bears the Burden and How

The FTC, FDA, and DEA must coordinate research, stakeholder consultation, publication, and possible redactions within one year. Social media platforms may face scrutiny of design features, seller activity, and mitigation practices. Law-enforcement agencies must help balance public transparency with protection of tactics and investigations.

Key Provisions

  • Requires the FTC, FDA, and DEA to report within one year on minors’ access to fentanyl through social media platforms.
  • Requires the report to assess prevalence, health risks, seller tactics, platform design features, platform countermeasures, and outside responses.
  • Requires recommendations for Congress to reduce minors’ ability to access fentanyl on social media.
  • Requires consultation with parents, platforms, law enforcement, medical professionals, and other experts.
  • Authorizes redaction of information that could compromise law-enforcement tactics, strategies, or techniques.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Requires the FTC, FDA, and DEA to report to Congress and the public on minors’ ability to access fentanyl through social media platforms and recommend ways to stop it.

Key Policy Areas

Technology, Drug Policy, Children

Primary Purpose

Requires the FTC, FDA, and DEA to report to Congress and the public on minors’ ability to access fentanyl through social media platforms and recommend ways to stop it.

Policy Domains

Technology Drug Policy Children

Substantive provisions

Identified Gains
  • Minors exposed to fentanyl risks
  • Parents of minors
  • Congressional commerce committees
  • Law enforcement agencies
  • Medical professionals
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Parents of minors:
Medical professionals:
Law enforcement agencies:
Minors exposed to fentanyl risks:
Congressional commerce committees:
Identified Costs
  • Federal Trade Commission
  • Food and Drug Administration
  • Drug Enforcement Administration
  • Social media platforms
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Social media platforms:
Federal Trade Commission:
Food and Drug Administration:
Drug Enforcement Administration:

Legislative Progress

In Committee
Introduced Committee Passed
Dec 11, 2025

Forwarded by Subcommittee to Full Committee by Voice Vote.

Dec 11, 2025

Subcommittee Consideration and Mark-up Session Held

Nov 21, 2025

Mr. Evans of Colorado (for himself and Mrs. Dingell) introduced …

Nov 21, 2025

Referred to the Subcommittee on Commerce, Manufacturing, and Trade.

Nov 21, 2025

Referred to the Committee on Energy and Commerce, and in …

Nov 21, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
3 mentions across 1 clause
+1 positive -2 negative

Congressional commerce committees, Federal Trade Commission, Food and Drug Administration

Positive-direction: Congressional commerce committees

Negative-direction: Federal Trade Commission, Food and Drug Administration

Consumers
2 mentions across 1 clause
+2 positive

Minors exposed to fentanyl risks, Parents of minors

Law Enforcement
1 mention across 1 clause
-1 negative

Drug Enforcement Administration

Technology
1 mention across 1 clause
-1 negative

Social media platforms

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Technology Drug Policy Children

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology